HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Immunicon Corporation (NASDAQ-GM:IMMC) today announced the availability of the EasyCount™ System, a fluorescent microscopy-based imaging system that accurately counts dead and live nucleated cells and automatically calculates cell viability, in a single test. Currently, most cell counting procedures are done manually using a microscope, which is a time-consuming and tedious process. The EasyCount™ System together with the EasyCount™ ViaSure™ Kit automate this routine function, eliminating the variability associated with the subjective interpretation of the manual method. The researcher can perform up to six tests at a time using the EasyCount™ Slide6™ Multi-Well Slide provided with the EasyCount™ ViaSure™ Kit and the instrument reports total and live cell counts and viability calculation in less than one minute per test. Immunicon will target research laboratories and industrial accounts including bioprocessing facilities in the pharmaceutical, biotechnology and diagnostics sectors, where rapid, accurate cell counting is valued highly by users.
